Squarepoint Ops LLC Makes New $290,000 Investment in Fresenius Medical Care AG (NYSE:FMS)

Squarepoint Ops LLC acquired a new position in Fresenius Medical Care AG (NYSE:FMS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 12,823 shares of the company's stock, valued at approximately $290,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Smartleaf Asset Management LLC grew its holdings in Fresenius Medical Care by 192.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock worth $28,000 after purchasing an additional 806 shares during the period. Russell Investments Group Ltd. grew its holdings in Fresenius Medical Care by 234.1% in the fourth quarter. Russell Investments Group Ltd. now owns 3,151 shares of the company's stock worth $71,000 after purchasing an additional 2,208 shares during the period. Jones Financial Companies Lllp grew its holdings in Fresenius Medical Care by 80.5% in the fourth quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company's stock worth $102,000 after purchasing an additional 2,012 shares during the period. Venturi Wealth Management LLC grew its holdings in Fresenius Medical Care by 8.4% in the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company's stock worth $129,000 after purchasing an additional 441 shares during the period. Finally, Assetmark Inc. grew its holdings in Fresenius Medical Care by 196.3% in the fourth quarter. Assetmark Inc. now owns 7,210 shares of the company's stock worth $163,000 after purchasing an additional 4,777 shares during the period. Hedge funds and other institutional investors own 8.37% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on FMS shares. Wall Street Zen started coverage on shares of Fresenius Medical Care in a report on Tuesday, May 20th. They issued a "strong-buy" rating on the stock. Truist Financial upped their target price on shares of Fresenius Medical Care from $25.00 to $30.00 and gave the stock a "hold" rating in a research note on Monday, May 12th. Finally, Morgan Stanley reiterated an "underweight" rating on shares of Fresenius Medical Care in a research note on Thursday, May 15th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, one has issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $27.80.

Fresenius Medical Care Stock Down 0.4%

Shares of Fresenius Medical Care stock opened at $28.53 on Friday. The company has a market cap of $16.74 billion, a price-to-earnings ratio of 23.58, a price-to-earnings-growth ratio of 0.76 and a beta of 0.85. The company's 50 day moving average is $26.35 and its 200 day moving average is $24.50. Fresenius Medical Care AG has a twelve month low of $17.93 and a twelve month high of $30.46. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42.

Fresenius Medical Care (NYSE:FMS - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.43 by $0.01. The company had revenue of $5.54 billion for the quarter, compared to the consensus estimate of $4.71 billion. Fresenius Medical Care had a net margin of 3.43% and a return on equity of 6.04%. Research analysts anticipate that Fresenius Medical Care AG will post 1.51 EPS for the current year.

Fresenius Medical Care Increases Dividend

The firm also recently announced an annual dividend, which was paid on Friday, June 6th. Shareholders of record on Friday, May 23rd were issued a dividend of $0.7871 per share. This is a boost from Fresenius Medical Care's previous annual dividend of $0.44. This represents a yield of 1.9%. The ex-dividend date was Friday, May 23rd. Fresenius Medical Care's dividend payout ratio is currently 49.11%.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Want to see what other hedge funds are holding FMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fresenius Medical Care AG (NYSE:FMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.